Biotech Values

[rkrw]

Just listened to the ceph call. Just me or was Baldino very testy? Sounded pissed at half the questions. Interesting how he closely monitors analyst reports--even specifically cited a couple of them and how the deal addresses analyst concerns.

ceph has a great track record with deals. Oravescent is as good as he thinks cima will turn out to be another.